MRC1 and neoplasm: Recently, nanobodies (Nbs) against macrophage mannose receptor (MMR) have been developed, and their potential as in vivo diagnostic tracers for non-invasive imaging a subpopulation of tumour-infiltrating macrophages [13, 14] and joint inflammation in rheumatoid arthritis [15] have been well documented.